| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 176,9 k € | ||||||||||||||||||
| Gross margin | 86,4 k € | +45.4% | 59,4 k € | -11.6% | 67,2 k € | -23.7% | 88,0 k € | +96.0% | 44,9 k € | -27.0% | 61,5 k € | +79.6% | 34,3 k € | -55.4% | 76,8 k € | +52.5% | 50,3 k € | +163.7% | 19,1 k € | -29.5% | 27,1 k € | -41.1% | 46,0 k € | -15.1% | 54,1 k € | +3.1% | 52,5 k € | +27.3% | 41,2 k € | -6.5% | 44,1 k € | -4.6% | 46,3 k € | -44.9% | 83,9 k € | |
| EBITDA | 85,3 k € | +47.6% | 57,8 k € | -13.3% | 66,6 k € | -23.4% | 87,0 k € | +97.7% | 44,0 k € | -27.3% | 60,5 k € | +81.3% | 33,4 k € | -52.4% | 70,2 k € | +42.6% | 49,2 k € | +173.7% | 18,0 k € | -30.7% | 26,0 k € | -42.0% | 44,8 k € | -13.8% | 52,0 k € | +6.2% | 49,0 k € | +22.7% | 39,9 k € | -7.1% | 43,0 k € | -4.9% | 45,2 k € | -45.2% | 82,4 k € | |
| Operating profit | 72,9 k € | +51.5% | 48,1 k € | -15.9% | 57,2 k € | -26.3% | 77,6 k € | +127.9% | 34,1 k € | -32.5% | 50,4 k € | +116.3% | 23,3 k € | -61.0% | 59,7 k € | +78.9% | 33,4 k € | +710.2% | 4,1 k € | -64.7% | 11,7 k € | -60.3% | 29,4 k € | -19.7% | 36,7 k € | -7.6% | 39,7 k € | +21.1% | 32,8 k € | -8.6% | 35,8 k € | -6.5% | 38,3 k € | -49.2% | 75,5 k € | |
| Profit/loss | 52,8 k € | +70.3% | 31,0 k € | -12.4% | 35,4 k € | -30.3% | 50,8 k € | +162.6% | 19,3 k € | -50.2% | 38,8 k € | +184.6% | 13,6 k € | -65.3% | 39,3 k € | +94.4% | 20,2 k € | +1506.6% | -1,4 k € | -121.3% | 6,7 k € | -67.6% | 20,8 k € | -26.9% | 28,4 k € | -15.1% | 33,5 k € | +49.0% | 22,5 k € | -6.5% | 24,0 k € | -3.9% | 25,0 k € | -41.4% | 42,6 k € | |
| Equity | 249,2 k € | +26.9% | 196,4 k € | -9.0% | 215,9 k € | +19.6% | 180,6 k € | -9.4% | 199,3 k € | +10.7% | 180,0 k € | +27.5% | 141,2 k € | -54.8% | 312,1 k € | +14.4% | 272,8 k € | +8.0% | 252,6 k € | -0.6% | 254,0 k € | +2.7% | 247,3 k € | -0.5% | 248,6 k € | +12.1% | 221,8 k € | +16.8% | 189,9 k € | +12.3% | 169,1 k € | +15.3% | 146,6 k € | +19.0% | 123,2 k € | |
| Total assets | 368,7 k € | +14.9% | 321,0 k € | -6.2% | 342,1 k € | -8.9% | 375,4 k € | +13.0% | 332,3 k € | +5.3% | 315,6 k € | +4.4% | 302,4 k € | -11.4% | 341,2 k € | +13.0% | 301,9 k € | +5.7% | 285,7 k € | -4.2% | 298,3 k € | -38.8% | 487,6 k € | +57.6% | 309,4 k € | +8.7% | 284,7 k € | +6.9% | 266,4 k € | +6.0% | 251,3 k € | +9.2% | 230,2 k € | +4.2% | 220,9 k € | |
| Cash | 114,1 k € | +62.5% | 70,2 k € | -69.2% | 227,8 k € | -4.3% | 237,9 k € | +17.6% | 202,3 k € | +18.8% | 170,3 k € | +25.6% | 135,5 k € | +27.2% | 106,6 k € | +38.0% | 77,3 k € | +643.0% | 10,4 k € | -77.4% | 46,0 k € | -79.6% | 225,5 k € | +457.1% | 40,5 k € | -48.2% | 78,2 k € | +16.8% | 67,0 k € | -16.1% | 79,8 k € | -33.3% | 119,5 k € | +66.3% | 71,9 k € | |
| Debts | 115,1 k € | -4.2% | 120,2 k € | +0.6% | 119,5 k € | -37.3% | 190,6 k € | +48.4% | 128,5 k € | -5.3% | 135,6 k € | -15.9% | 161,2 k € | +466.8% | 28,4 k € | +0.3% | 28,4 k € | -12.5% | 32,4 k € | -25.6% | 43,6 k € | -81.8% | 239,6 k € | +299.3% | 60,0 k € | -3.4% | 62,1 k € | -17.7% | 75,4 k € | -7.5% | 81,5 k € | -1.3% | 82,6 k € | -14.6% | 96,7 k € | |
Private company with limited liability profitable and well capitalised. Cash position rising (+62.5%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
DOCTEUR YVAN CALOZET is a Private company with limited liability incorporated in 2002. Its main activity is: Other human health activities. Its registered office is in Herbeumont.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette